Showing results (271-280 of 297) with videos related to
Sort By:
Pageof 30
Neurology|February 28, 2002
Association and linkage of juvenile MS with HLA-DR2(15) in RussiansA N Boiko, E I Gusev, M A Sudomoina, et al.Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|May 12, 2009
[Pharmacoresistant temporal epilepsy: surgical treatment and analysis of factors influencing on its results]A N Konovalov, E I Gusev, A B Gekht, et al.Radiation and Environmental Biophysics|March 7, 2008
Iodine-129 measurements in soil samples from Dolon village near the Semipalatinsk nuclear test siteSatoru Endo, Junpei Tomita, Kenichi Tanaka, et al.Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|October 18, 2008
[Pathophysiological mechanisms of hemorrhagic stroke and the ways of differential therapy]E I Gusev, V A Stonik, M Iu Martynov, et al.Neurology|August 27, 2003
Myelin basic protein gene is associated with MS in DR4- and DR5-positive Italians and RussiansF R Guerini, P Ferrante, L Losciale, et al.Neuropsychobiology|April 6, 2018
Association of Polymorphisms of Serotonin Transporter (5HTTLPR) and 5-HT2C Receptor Genes with Criminal Behavior in Russian Criminal OffendersValentina A Toshchakova, Yalda Bakhtiari, Alexander V Kulikov, et al.Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|August 27, 2003
[Association between DNA antibodies levels in the blood of patients with multiple sclerosis and clinical presentation of the disease]N A Ershova, N V Garmashova, V N Buneva, et al.Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|June 9, 2012
[Efficacy and tolerability of long-term using of glatimer acetate (copaxone): a 10 year-study in the Moscow Municipal Multiple Sclerosis center]A N Boĭko, M V Davydovskaia, T L Demina, et al.Molekuliarnaia Biologiia|February 3, 2012
[Pharmacogenomics of multiple sclerosis: association of immune response genes polymorphism with copaxone treatment efficacy]E Iu Tsareva, O G Kulakova, O Iu Makarycheva, et al.Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|September 3, 2025
[Results of the implementation of reperfusion technologies in ischemic stroke]N A Shamalov, D R Khasanova, I A Voznyuk, et al.Pageof 30